Litcius/Paper detail

Oncolytic Vaccinia Virus Carrying Aphrocallistes vastus Lectin (oncoVV-AVL) Enhances Inflammatory Response in Hepatocellular Carcinoma Cells

Xinnan Zheng, Weizhe Xu, Qi Ying, Jiajun Ni, Xiaoyuan Jia, Yanrong Zhou, Ting Ye, Gongchu Li, Kan Chen

2022Marine Drugs16 citationsDOIOpen Access PDF

Abstract

lectin (AVL) is a C-type marine lectin derived from sponges. Our previous study demonstrated that oncolytic vaccinia virus carrying AVL (oncoVV-AVL) significantly enhanced the cytotoxicity of oncoVV in cervical cancer, colorectal cancer and hepatocellular carcinoma through the activation of Ras/ERK, MAPK/ERK and PI3K/Akt signaling pathways. In this study, the inflammatory response induced by oncoVV-AVL in a hepatocellular carcinoma cell (HCC) model was investigated. The results showed that oncoVV-AVL increased the levels of inflammatory cytokines including IL-6, IL-8 and TNF-α through activating the AP-1 signaling pathway in HCC. This study provides novel insights into the utilization of lectin AVL in the field of cancer therapy.

Topics & Concepts

Oncolytic virusCancer researchMAPK/ERK pathwayHepatocellular carcinomaLectinPI3K/AKT/mTOR pathwayVacciniaMedicineTumor necrosis factor alphaProtein kinase BVirusImmunologyBiologySignal transductionCell biologyBiochemistryGeneRecombinant DNAVirus-based gene therapy researchViral Infectious Diseases and Gene Expression in InsectsCancer Research and Treatments